Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sprinter Health has completed nearly 100,000 in-home visits across 18 states as of mid-2025. Its model combines W2-employed phlebotomists/community health workers ("Sprinters") with a virtual team of clinicians to close preventive care gaps for hard-to-reach populations. The company reports high growth rates and strong engagement metrics but does not publish traditional "clinical trial" results as it is a service provider rather than a drug developer
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sprinter Health.